Treatment at a high-volume centre is associated with improved survival among patients with non-metastatic hepatocellular carcinoma.
Emma B HollidayPamela K AllenHesham ElhalawaniOmar Abdel-RahmanPublished in: Liver international : official journal of the International Association for the Study of the Liver (2017)
Receiving treatment at a high-volume centre is significantly associated with survival for patients with non-metastatic disease. Improved survival at high-volume centres may be related to access to a variety of treatment modalities, multidisciplinary evaluation, and/or subspecialty expertise.